Quantcast

Latest Clinical research Stories

2014-09-05 23:03:28

On September 2, the FDA announced that Solace International, Inc. is recalling all lots of Dermatend Original and Dermatend Ultra due to safety concerns. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Dermatend Original and Dermatend Ultra....

2014-09-05 08:23:23

MELBOURNE, Australia, Sept. 5, 2014 /PRNewswire/ -- Prana Biotechnology (ASX: PBT) has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease. Orphan drug designation is granted by the FDA to promote the development of drugs for diseases affecting less than 200,000 people in the United States. Orphan drug designation entitles Prana to seven years of market exclusivity for the use of PBT2 in the...

2014-09-05 08:23:21

PITTSBURGH, Sept. 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version of Hoffmann-La Roche's Boniva® Injection. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of osteoporosis in...

2014-09-04 12:21:31

Conference attendees get chance to discuss visibility, collaboration and brand protection challenges with the experts MARLTON, N.J., Sept. 4, 2014 /PRNewswire/ -- Acsis Inc., the market leader for supply chain visibility, brand protection and serialization solutions, announced the company will be attending two major pharmaceutical industry conferences in September - PDA/FDA Joint Regulatory Conference, September 8-9 at the Renaissance Hotel, Washington DC, Booth # 58; and LogiPharma,...

2014-09-04 08:29:33

BOSTON, Sept. 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Dr. Tracy Tsuetaki as Senior Vice President for Peri/Post-Approval Services and PAREXEL Consulting. He will oversee the strategy and operational management for both businesses. He will also serve on PAREXEL's Business Review Committee, the Company's senior-most leadership team, and assist in developing and...

2014-09-03 23:14:59

On August 26, Mars Petcare US announced the recall of specific bags of Pedigree Adult Complete Nutrition dry dog food products due to the possible presence of a foreign material. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 03, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Pedigree...

2014-09-03 23:11:45

Pew, Blue Cross Blue Shield Association, and MDEpiNet report captures recommendations of 30 diverse health care experts Washington, DC (PRWEB) September 03, 2014 Three organizations today proposed wide-ranging recommendations on the development of registries to address the country’s lack of a robust national system for assessing the safety and effectiveness of medical devices. Registries, which contain information on patients treated with specific medical devices, could fill this gap...

2014-09-03 12:31:52

Nearly 20 New Multi-Year iMedNet Agreements Signed Year-to-Date MINNETONKA, Minn., Sept. 3, 2014 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that sponsors and CROs around the world are increasingly selecting iMedNet(TM) EDC as their eClinical solution of choice. New iMedNet customers include multiple Top 10 Clinical Research Organizations (CROs) as well as Top 10 pharmaceutical/animal...

2014-09-03 08:34:15

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Halozyme's program investigating PEGPH20 (PEGylated recombinant human hyaluronidase) in combination with gemcitabine and nab-paclitaxel for the treatment of patients with metastatic pancreatic cancer to demonstrate an improvement in overall survival. The Fast Track designation process was developed...

2014-09-03 08:34:10

Company CEO to present at both the Rodman & Renshaw Global Investment Conference and Aegis Capital 2014 Healthcare and Technology Conference in September JERUSALEM, September 3, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com [http://c/Users/Aviva - Oramed/EFN Synced Tool/.CORPORATE/Public Relations/PressReleases/Press Releases/2014/NEW RELEASES - checking/www.oramed.com ] ), a clinical-stage pharmaceutical company focused on the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related